Maximilian Koch's Colleagues at Monte Rosa Therapeutics
Agustin Chicas
Director of Biology/ Head of Translational Drug Discovery (Boston)
Maximilian Koch's Contact Details
N/A
Liestal,Basel-Landschaft,4410,Switzerland
Monte Rosa Therapeutics
Maximilian Koch's Company Details
Small molecule protein degraders are set to reshape the way by which diseases will be treated. Our rational approach in targeting disease-causing proteins for degradation will deliver pioneering therapies for cancer and beyond. Headquartered in Boston with additional laboratory facilities in Basel, Monte Rosa Therapeutics is a private company launched in 2020. Initially seeded by Versant Ventures and incubated at Ridgeline Discovery in Basel, and The Institute of Cancer Research in London, Monte Rosa has raised $32.5 million from Versant and New Enterprise Associates. Academic co-founders are Prof. Raj Chopra and Prof. Ian Collins of The Institute for Cancer Research, UK.